Veracyte Insider Trades
NASDAQ: VCYTHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 28 · $14.11M
- Shares bought / sold
- 0 / 313.37K
- Net activity
- Net selling $14.1 million
Veracyte insider activity
Over the last 12 months, Veracyte insiders reported 63 transactions on SEC Form 4: 0 open-market purchases and 28 sales. Insiders bought $0 and sold $14.1 million worth of stock, for net insider selling of $14.1 million. The largest seller was Stapley Marc, with $8.6 million in reported sales.
The most recent filing shows Leite John (Global Chief Commercial Off) selling 4,015 shares at $40.00 on Sep 21, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VCYT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VCYT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 21, 2026 | Leite JohnGlobal Chief Commercial Off | Sale | 4,015 | $160.60K | Form 4 |
| Sep 14, 2026 | Holstein JensDirector | Sale | 5,000 | $204.75K | Form 4 |
| Sep 4, 2026 | McGuire AnnieEVP, General Counsel | Sale | 1,100 | $48.04K | Form 4 |
| Sep 4, 2026 | McGuire AnnieEVP, General Counsel | Sale | 2,154 | $92.17K | Form 4 |
| Sep 4, 2026 | Chambers RebeccaChief Financial Officer | Sale | 1,175 | $51.36K | Form 4 |
| Sep 4, 2026 | Chambers RebeccaChief Financial Officer | Sale | 2,477 | $106.03K | Form 4 |
| Sep 4, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Sale | 2,705 | $118.11K | Form 4 |
| Sep 4, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Sale | 10,405 | $446.30K | Form 4 |
| Sep 2, 2026 | Leite JohnGlobal Chief Commercial Off | Tax withholding | 3,961 | $177.77K | Form 4 |
| Sep 2, 2026 | Wygant JonathanVP, Chief Accounting Officer | Tax withholding | 1,361 | $61.08K | Form 4 |
| Sep 2, 2026 | Stapley MarcChief Executive Officer | Tax withholding | 8,782 | $394.14K | Form 4 |
| Sep 2, 2026 | McGuire AnnieEVP, General Counsel | Tax withholding | 3,215 | $144.29K | Form 4 |
| Sep 2, 2026 | Chambers RebeccaChief Financial Officer | Tax withholding | 3,603 | $161.70K | Form 4 |
| Sep 2, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Tax withholding | 3,639 | $163.32K | Form 4 |
| Sep 1, 2026 | Bhanji MunaDirector | Sale | 1,864 | $80.10K | Form 4 |
| Jun 18, 2026 | EASTHAM KARINDirector | Sale | 529 | $28.33K | Form 4 |
| Jun 18, 2026 | EASTHAM KARINDirector | Sale | 3,200 | $168.91K | Form 4 |
| Jun 11, 2026 | Miller Thomas F.Director | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | Bhanji MunaDirector | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | Holstein JensDirector | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | EPSTEIN ROBERT SDirector | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | Shafer David BrentDirector | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | JONES EVAN/ FADirector | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | EASTHAM KARINDirector | Award | 5,272 | — | Form 4 |
| Jun 11, 2026 | Barr EliavDirector | Award | 5,272 | — | Form 4 |
| Jun 4, 2026 | Leite JohnGlobal Chief Commercial Off | Sale | 13,975 | $699.73K | Form 4 |
| Jun 4, 2026 | Stapley MarcChief Executive Officer | Sale | 138,051 | $6.92M | Form 4 |
| Jun 4, 2026 | Stapley MarcChief Executive Officer | Option exercise | 138,051 | $5.05M | Form 4 |
| Jun 4, 2026 | McGuire AnnieEVP, General Counsel | Sale | 1,776 | $89.01K | Form 4 |
| Jun 4, 2026 | McGuire AnnieEVP, General Counsel | Sale | 1,400 | $69.03K | Form 4 |
| Jun 4, 2026 | Chambers RebeccaChief Financial Officer | Sale | 1,961 | $98.23K | Form 4 |
| Jun 4, 2026 | Chambers RebeccaChief Financial Officer | Sale | 1,600 | $78.85K | Form 4 |
| Jun 2, 2026 | Leite JohnGlobal Chief Commercial Off | Tax withholding | 4,059 | $194.02K | Form 4 |
| Jun 2, 2026 | Stapley MarcChief Executive Officer | Tax withholding | 9,012 | $430.77K | Form 4 |
| Jun 2, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Tax withholding | 3,730 | $178.29K | Form 4 |
| Jun 2, 2026 | Wygant JonathanVP, Chief Accounting Officer | Tax withholding | 1,361 | $65.06K | Form 4 |
| Jun 2, 2026 | McGuire AnnieEVP, General Counsel | Tax withholding | 3,292 | $157.36K | Form 4 |
| Jun 2, 2026 | Chambers RebeccaChief Financial Officer | Tax withholding | 3,693 | $176.53K | Form 4 |
| May 22, 2026 | Wygant JonathanVP, Chief Accounting Officer | Sale | 24,000 | $1.09M | Form 4 |
| May 22, 2026 | Wygant JonathanVP, Chief Accounting Officer | Option exercise | 24,000 | $595.20K | Form 4 |
| May 20, 2026 | EPSTEIN ROBERT SDirector | Sale | 10,000 | $440.13K | Form 4 |
| May 6, 2026 | McGuire AnnieSVP, General Counsel | Sale | 5,102 | $204.08K | Form 4 |
| May 6, 2026 | McGuire AnnieSVP, General Counsel | Sale | 5,102 | $194.13K | Form 4 |
| Apr 10, 2026 | Haas Kevin RichardChief Dev and Tech Officer | Award | 44,221 | — | Form 4 |
| Mar 6, 2026 | Stapley MarcChief Executive Officer | Award | 92,099 | — | Form 4 |
| Mar 6, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Award | 6,578 | — | Form 4 |
| Mar 6, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Award | 29,603 | — | Form 4 |
| Mar 6, 2026 | McGuire AnnieSVP, General Counsel | Award | 26,314 | — | Form 4 |
| Mar 6, 2026 | McGuire AnnieSVP, General Counsel | Award | 32,892 | — | Form 4 |
| Mar 6, 2026 | Chambers RebeccaChief Financial Officer | Award | 13,157 | — | Form 4 |
| Mar 6, 2026 | Chambers RebeccaChief Financial Officer | Award | 36,181 | — | Form 4 |
| Mar 6, 2026 | Wygant JonathanVP, Chief Accounting Officer | Award | 10,525 | — | Form 4 |
| Mar 6, 2026 | Leite JohnChief Commercial Officer-CLIA | Award | 6,578 | — | Form 4 |
| Mar 6, 2026 | Leite JohnChief Commercial Officer-CLIA | Award | 36,181 | — | Form 4 |
| Mar 4, 2026 | Leite JohnChief Commercial Officer-CLIA | Sale | 5,260 | $185.08K | Form 4 |
| Mar 4, 2026 | Stapley MarcChief Executive Officer | Sale | 26,279 | $953.37K | Form 4 |
| Mar 4, 2026 | Stapley MarcChief Executive Officer | Sale | 19,244 | $684.23K | Form 4 |
| Mar 4, 2026 | McGuire AnnieSVP, General Counsel | Sale | 1,664 | $60.47K | Form 4 |
| Mar 4, 2026 | McGuire AnnieSVP, General Counsel | Sale | 4,994 | $176.26K | Form 4 |
| Mar 4, 2026 | Chambers RebeccaChief Financial Officer | Sale | 13,941 | $506.46K | Form 4 |
| Mar 4, 2026 | Chambers RebeccaChief Financial Officer | Sale | 4,400 | $156.41K | Form 4 |
| Mar 2, 2026 | Wygant JonathanVP, Chief Accounting Officer | Tax withholding | 3,006 | $108.25K | Form 4 |
| Mar 2, 2026 | McGuire AnnieSVP, General Counsel | Tax withholding | 6,902 | $248.54K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4